Optimization of release pattern of FGF-2 and BMP-2 for osteogenic differentiation of low-population density hMSCs.

In the modern design, most delivery systems for bone regeneration focus on a single growth factor (GF) or a simple mixture of multiple GFs, overlooking the coordination of proliferation and osteogenesis induced by various factors. In this study, core-shell microspheres with poly-l-lactide core-poly(lactic-co-glycolic acid) shell were fabricated, and two GFs, basic fibroblast growth factor 2 (FGF-2) and bone morphogenetic protein 2 (BMP-2) were encapsulated into the core or/and shell. The effects of different release patterns (parallel or sequential manners) of FGF-2 and BMP-2 from these core-shell microspheres on the osteogenic differentiation of low-population density human mesenchymal stem cells (hMSCs) were investigated and the temporal organization of GF release was optimized. In vitro experiments suggested that induction of osteogenic differentiation of low-population density hMSCs by the sequential delivery of FGF-2 followed by BMP-2 from the core-shell microspheres (group S2) was much more efficient than that by the parallel release of the two factors from uniform microspheres (group U). The osteogenic induction by the sequential delivery of BMP-2 followed by FGF-2 from core-shell microspheres (group S1) was even worse than that from microspheres loaded with BMP-2 in both core and shell (group B), although comparable to the cases of parallel delivery of dual GFs (group P). This study showed the advantages of group S2 microspheres in inducing osteogenic differentiation of low-population density hMSCs and the necessity of time sequence studies in tissue engineering while multiple GFs are involved.

[1]  Chi‐Hwa Wang,et al.  Paclitaxel and suramin-loaded core/shell microspheres in the treatment of brain tumors. , 2010, Biomaterials.

[2]  Ho Sup Yoon,et al.  Co-delivery of drugs and DNA from cationic core–shell nanoparticles self-assembled from a biodegradable copolymer , 2006, Nature materials.

[3]  G. Vunjak‐Novakovic,et al.  Growth factors for sequential cellular de- and re-differentiation in tissue engineering. , 2002, Biochemical and biophysical research communications.

[4]  Z. Gan,et al.  The influence of pendant hydroxyl groups on enzymatic degradation and drug delivery of amphiphilic poly[glycidol-block-(epsilon-caprolactone)] copolymers. , 2009, Macromolecular bioscience.

[5]  R. Zernicke,et al.  Osteogenic response of bone marrow stromal cells from normal and ovariectomized rats treated with a low dose of basic fibroblast growth factor. , 2007, Tissue engineering.

[6]  Bing Chen,et al.  Regeneration of uterine horns in rats by collagen scaffolds loaded with collagen-binding human basic fibroblast growth factor. , 2011, Biomaterials.

[7]  David F Williams,et al.  To engineer is to create: the link between engineering and regeneration. , 2006, Trends in biotechnology.

[8]  Michael J Yaszemski,et al.  Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. , 2009, Biomaterials.

[9]  V. Hasırcı,et al.  Sequential BMP-2/BMP-7 delivery from polyester nanocapsules. , 2009, Journal of biomedical materials research. Part A.

[10]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[11]  Samir Mitragotri,et al.  Oral delivery of macromolecules using intestinal patches: applications for insulin delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[12]  Lai Yeng Lee,et al.  Lysine-based peptide-functionalized PLGA foams for controlled DNA delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[13]  L. Chaudhary,et al.  Differential growth factor control of bone formation through osteoprogenitor differentiation. , 2004, Bone.

[14]  A. Vercoutter-Edouart,et al.  FGF signals for cell proliferation and migration through different pathways. , 2000, Cytokine & growth factor reviews.

[15]  P. Ho,et al.  A nanocapsular combinatorial sequential drug delivery system for antiangiogenesis and anticancer activities. , 2010, Biomaterials.

[16]  P. Marie,et al.  Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling. , 2002, Histology and histopathology.

[17]  Stefan Fischer,et al.  Cell death in human lung transplantation: apoptosis induction in human lungs during ischemia and after transplantation. , 2000, Annals of surgery.

[18]  Robert Langer,et al.  Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[19]  M. Rouabhia,et al.  Effect of BMP-2 and BMP-7 homodimers and a mixture of BMP-2/BMP-7 homodimers on osteoblast adhesion and growth following culture on a collagen scaffold , 2008, Biomedical materials.

[20]  Thomas A Einhorn,et al.  Differential Temporal Expression of Members of the Transforming Growth Factor β Superfamily During Murine Fracture Healing , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  G. Hansmann,et al.  An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension. , 2008, The Journal of clinical investigation.

[22]  L. Chaudhary,et al.  Extracellular‐signal regulated kinase signaling pathway mediates downregulation of type I procollagen gene expression by FGF‐2, PDGF‐BB, and okadaic acid in osteoblastic cells , 2000, Journal of cellular biochemistry.

[23]  Helen M. Blau,et al.  Biological Progression from Adult Bone Marrow to Mononucleate Muscle Stem Cell to Multinucleate Muscle Fiber in Response to Injury , 2002, Cell.

[24]  Robert Langer,et al.  Formulation and characterization of poly (beta amino ester) microparticles for genetic vaccine delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[25]  Francesca Ungaro,et al.  Controlled drug delivery in tissue engineering. , 2008, Advanced drug delivery reviews.

[26]  W. Sebald,et al.  In Vitro Osteogenic Response of Rat Bone Marrow Cells to bFGF and BMP-2 Treatments , 2006, Clinical orthopaedics and related research.

[27]  David J Mooney,et al.  Designing scaffolds to enhance transplanted myoblast survival and migration. , 2006, Tissue engineering.

[28]  Antonios G Mikos,et al.  In vitro release of plasmid DNA from oligo(poly(ethylene glycol) fumarate) hydrogels. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[29]  G. Vunjak‐Novakovic,et al.  Enhanced cartilage tissue engineering by sequential exposure of chondrocytes to FGF‐2 during 2D expansion and BMP‐2 during 3D cultivation , 2001, Journal of cellular biochemistry.

[30]  Y. Kato,et al.  Local Application of Basic Fibroblast Growth Factor Minipellet Induces the Healing of Segmental Bony Defects in Rabbits , 1998, Calcified Tissue International.

[31]  K. Nagata,et al.  Platelet-derived growth factor and bone morphogenetic protein in the healing of mandibular fractures in rats. , 2003, The British journal of oral & maxillofacial surgery.

[32]  D. Y. Arifin,et al.  Core/shell microspheres via coaxial electrohydrodynamic atomization for sequential and parallel release of drugs. , 2010, Journal of biomedical materials research. Part A.

[33]  D. Skuk,et al.  Complement deposition and cell death after myoblast transplantation. , 1998, Cell transplantation.

[34]  C. Ellis,et al.  Fibroblast growth factor-2 potentiates vascular smooth muscle cell migration to platelet-derived growth factor: upregulation of alpha2beta1 integrin and disassembly of actin filaments. , 1997, Circulation research.

[35]  P. Giannoudis,et al.  The Effect of Bone Morphogenetic Protein-2, Bone Morphogenetic Protein-7, Parathyroid Hormone, and Platelet-Derived Growth Factor on the Proliferation and Osteogenic Differentiation of Mesenchymal Stem Cells Derived From Osteoporotic Bone , 2010, Journal of orthopaedic trauma.